As climate pressures reshape global viticulture, Banfi is investing in rootstock research and clonal diversity to ...
Apnimed, Inc., a pharmaceutical company developing an oral drug product candidate, AD109, that is designed to address a root cause of obstructive sleep apnea (OSA), today announced that Shionogi & Co.
Stephen Tahija Courtesy of Next Generation Pest Control Your home and yard may be the unwitting home to a handful of species ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results